Thomas L. Schwartz, MD: The Use of Tiagabine Augmentation for Treatment-Resistant Anxiety Disorders: A Case Series

Name: Thomas L. Schwartz, MD: The Use of Tiagabine Augmentation for Treatment-Resistant Anxiety Disorders: A Case Series
SKU: 3216
Availability: InStock

$30.00

Want a discount? Become a member by purchasing Psychopharmacology Bulletin Subscription - Individual!

Categories: Psychopharmacology Bulletin, VOL 36 No. 2 Articles Tags: anxiety-disorder, anxiolytic, medworks-media, pharmacotherapy, psychopharmacology-bulletin, thomas-l-schwartz, tiagabine, treatment-resistance

Description

Thomas L. Schwartz, MD: The Use of Tiagabine Augmentation for Treatment-Resistant Anxiety Disorders: A Case Series

Description

Thomas L. Schwartz, MD

COMPLICATED CASE HISTORIES

The Use of Tiagabine Augmentation for Treatment-Resistant Anxiety Disorders: A Case Series

Thomas L. Schwartz, MD

Ramelteon for Insomnia Related to (ADHD) by Rachel E. Fargason

Clinical Predictors of Response to Clozapine by Rajkumar A.P.

Agomelatine for Depression in Schizophrenia by Jochen Mutschler

Antipsychotic Induced Symptomatic Hyperprolactinemia

Thomas L. Schwartz, MD: The Use of Tiagabine Augmentation for Treatment-Resistant Anxiety Disorders: A Case Series

Description

Thomas L. Schwartz, MD

COMPLICATED CASE HISTORIES

The Use of Tiagabine Augmentation for Treatment-Resistant Anxiety Disorders: A Case Series

Thomas L. Schwartz, MD

Related products

Ramelteon for Insomnia Related to (ADHD) by Rachel E. Fargason

Clinical Predictors of Response to Clozapine by Rajkumar A.P.

Agomelatine for Depression in Schizophrenia by Jochen Mutschler

Antipsychotic Induced Symptomatic Hyperprolactinemia